Teva Shoots Back With Suit Against Pfizer
Teva’s suit, filed in the U.S. Southern District Court of New York, seeks to reject claims that its drug azithromycin, and materials related to it, infringed on Pfizer’s patent.
More specifically, the suit seeks a declaratory judgement of non-infringement and patent invalidity.
When Zithromax came...
To view the full article, register now.